Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Apoptosis modulators reported in patent literature

Aug. 22, 1997

Telomerase-inhibitory oligonucleotides for treating cancer

Aug. 22, 1997

Laserscope receives approvable letter from FDA

Aug. 21, 1997

New antitumor agents discovered at Sagami

Aug. 21, 1997

NIH announces discovery of new breast cancer gene

Aug. 20, 1997

Pfizer enters phase I trials with CP-358774

Aug. 20, 1997

Endorex licenses anticancer drug perillyl alcohol

Aug. 20, 1997

Bristol-Myers Squibb describes new taxanes

Aug. 19, 1997

VEGF RTK inhibitors in the pipeline at Zeneca

Aug. 18, 1997

Terrapin and Taiho sign development agreement for anticancer agent

Aug. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...